Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-26

Clinical Trial Update: Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Probands

View source ↗

Summary

A study to develop and validate a risk prediction model for ovarian cancer among relatives of ovarian cancer probands. The research considers hereditary Breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Peking University Third Hospital | Conditions: Hereditary Breast and Ovarian Cancer Syndrome, BRCA Mutations | Status: RECRUITING